← Open Payments lookup

LUCY MUIGAI: Open Payments

NPI 1043437809 · WEST SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,013 in 78 payments from 16 companies in 2025. Trend: 2023 $3,208 · 2024 $1,849 · 2025 $2,013

Food & beverage: $1,790Education: $223
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.14$533
Otsuka America Pharmaceutical, Inc.12$255
Gilead Sciences, Inc.9$241
Lilly USA, LLC8$190
ABBVIE INC.5$106
Neurocrine BioSciences, Inc.4$106
Biogen, Inc.5$100
Aimmune Therapeutics, Inc.4$81
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$75
GlaxoSmithKline, LLC.3$71

Products named: REXULTI, AUSTEDO XR, MOUNJARO, INGREZZA, LEQEMBI, VRAYLAR, UZEDY, CAPLYTA.

Industry payments across MA — which companies pay providers there.